On Thursday, in the course of current trade, Shares of Nielsen Holdings PLC (NYSE:NLSN), climbed 0.68%, and is now trading at $45.68.
Nielsen, declared the launch of the Nielsen-Culturati Hispanic Segmentation. This new partnershipcombines the power of Nielsen’s Homescan Panel data with the depth of understanding of Culturati’s attitudes and values-based U.S. Hispanic segmentation model.
With this launch, the breadth of Hispanic consumer measurement is extended beyond just language and demographics to incorporate important factors such as attitudes and values. Culturati’s segmentation model uncovers the motivation behind shopper and consumer behavior. With this model, marketers will be able to maximize their Hispanic marketing investments by developing the right marketing plans, in-store programs and communications strategies.
“The combined capabilities of Nielsen and Culturati really provide an exciting new way to capture the total U.S. Hispanic landscape,” said Monica Gil, SVP and General Manager of Multicultural Growth and Strategy at Nielsen. “This new segmentation can be an important tool for our clients trying to appeal to Hispanic consumers since distinctions and nuances between each sub-segment of the Hispanic consumer market are revealed. The need to distinguish these differences is becoming more important because the cohorts are growing. Our clients need to understand the commonalities and differences among the Hispanic consumer set, and we are certain that this new segmentation will contribute to that aim.”
Nielsen N.V. operates as an information and measurement company. The company provides media and marketing information, analytics, and manufacturer and retailer expertise about what and where consumers buy, read, watch and listen.
During an Afternoon trade, Shares of Baytex Energy Corp (USA) (NYSE:BTE), dipped -2.08%, and is now trading at $5.17.
Baytex Energy Corp., declared that James Bowzer, President and CEO, will be presenting at the Barclays CEO Energy-Power Conference on Wednesday, September 9, 2015 at 9:05 am EDT (7:05 am MDT) in New York, New York.
Baytex Energy Corp., an oil and gas company, engages in the acquisition, development, exploitation, and production of oil and natural gas in the Western Canadian Sedimentary Basin and the United States.
Shares of Johnson Controls Inc (NYSE:JCI), during its Thursday’s current trading session fell 0.93%, and is now trading at $40.05.
CBRE Group, declared that it has closed the acquisition of Johnson Controls, Inc.’s (JCI) Global Workplace Solutions business. Global Workplace Solutions is a market-leading provider of enterprise facilities administration solutions for global corporations and other large occupiers of commercial real estate. Global Workplace Solutions had revenue of more than $3.0 billion in calendar year 2014.
“This is a very exciting step for CBRE,” said Bob Sulentic, the company’s president and chief executive officer. “It advances our strategy of delivering the highest quality, globally integrated services to major occupiers and builds our relationships with many of the world’s most prominent corporations. We are assisting our clients to enhance their competitive position by aligning every aspect of how they lease, own, use and operate real estate.”
The advantages of outsourcing real estate services, coupled with the high quality of CBRE’s offering, have fueled long-term, double-digit revenue growth for its occupier outsourcing business line. The addition of Global Workplace Solutions’ expertise around the world in technical engineering, supply chain administration, critical facilities and other capabilities adds significantly to CBRE’s already-robust service offering for occupiers.
Johnson Controls, Inc. operates as a diversified technology and industrial company worldwide. Its Building Efficiency segment designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, in addition to building administration systems, controls, and security and mechanical equipment.
Finally, Eli Lilly and Co (NYSE:LLY), gained 0.07% Thursday.
The U.S. Food and Drug Administration, has approved Synjardy (empagliflozin and metformin hydrochloride) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (LLY), for the treatment of adults with type 2 diabetes (T2D). SYNJARDY is the third product containing empagliflozin to be approved by the FDA, following Jardiance (empagliflozin) and Glyxambi (empagliflozin/linagliptin).
SYNJARDY is a combination of empagliflozin and metformin — two medicines with complementary mechanisms of action — to assist control blood glucose in people with T2D. Empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor, removes excess glucose through the urine by blocking glucose re-absorption in the kidney. Metformin, a commonly prescribed initial treatment for T2D, lowers glucose production by the liver and its absorption in the intestine.
“SYNJARDY is now the fifth FDA-approved medicine to emerge from the BI-Lilly Diabetes alliance pipeline in the last four years,” said Paul Fonteyne, president and CEO, BIPI. “No two people with diabetes are alike, and every experience is different. Our alliance is proud to offer a diverse portfolio of treatments that can assist patients throughout their diabetes journey.”
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
